CheckMyRecalls

MYLAN PHARMACEUTICALS INC recalls Mycophenolate Mofetil for Injection…

MYLAN PHARMACEUTICALS INC recalls Mycophenolate Mofetil for Injection USP

Published
5 Aug 2026
Units affected
5688 vials
Agency
FDA
Country
United States

The hazard

Presence of precipitate

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).

Brand / company
MYLAN PHARMACEUTICALS INC
Codes / lots
Lot #: 3241653, Exp 4/30/2027
Distribution
USA Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 5 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.